e-ISSN: Pending
Negative / Null Result ReportOpen accessMedicine· cited by 29

Adjuvant chemotherapy does not benefit patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy

Mingqiu Chen; Minmin Shen; Yu Lin; Pingping Liu; Xiaohong Liu; Xiqing Li; Anchuan Li; Rongqiang Yang · 2018 · Radiation Oncology

WASTE classifies this as Negative / Null Result Report · AI classification, approximate

The study found no significant effect — useful as a negative control or null benchmark for your own design.

Abstract

BACKGROUND: The aim of the present study was to assess the efficacy of adjuvant chemotherapy (AC) in patients with esophageal squamous cell carcinoma (ESCC) treated with definitive chemoradiotherapy (CRT). METHODS: The clinical data of patients with ESCC treated with chemoradiotherapy with or without AC were collected and retrospectively reviewed. The overall survival (OS), locoregional failure-free survival (LFFS) and distant failure-free survival (DFFS) rates were analyzed statistically. RESULTS: A total of 187 patients fulfilled the inclusion criteria, 98 of whom were treated with CRT-alone

Abstract by Mingqiu Chen; Minmin Shen; Yu Lin; Pingping Liu; Xiaohong Liu; Xiqing Li; Anchuan Li; Rongqiang Yang, Radiation Oncology (2018) — licensed CC BY 4.0.

About to run something similar?

Run an AI Precheck on your own design to catch failure modes like this one before you spend the time. Your first desk check is free.

WASTE indexes this work — it does not host or republish it. Failure-type classification is automated and approximate.

Metadata source: OpenAlex · DOI 10.1186/s13014-018-1086-y